TY - JOUR AU - Borg, Rikke AU - Persson, Frederik PY - 2017 TI - Empagliflozin reduces albuminuria—a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial JF - Annals of Translational Medicine; Vol 5, No 23 (December 07, 2017): Annals of Translational Medicine Y2 - 2017 KW - N2 - Nowadays, type 2 diabetes care covers much more than lowering of blood glucose. To prevent and treat both micro- and macrovascular complications, risk factors like blood pressure and dyslipidemia are equally important treatment targets. UR - https://atm.amegroups.org/article/view/17352